Nucleocapsid serum antigen determination in SARS-CoV-2 infected patients using the single molecule array technology and prediction of disease severity

J Infect. 2022 Apr;84(4):e4-e6. doi: 10.1016/j.jinf.2022.01.023. Epub 2022 Jan 21.
No abstract available

Keywords: Antigenic assay; COVID-19; RT-PCR; SARS-CoV-2; disease severity.

Publication types

  • Letter

MeSH terms

  • Antibodies, Viral
  • COVID-19*
  • Humans
  • Nucleocapsid
  • SARS-CoV-2*
  • Sensitivity and Specificity
  • Severity of Illness Index
  • Technology

Substances

  • Antibodies, Viral